NACI stands by its four month dosing interval but does not provide further evidence that this will work well for all age groups and for those with complicating medical conditions. Hope the gamble works (truly, no sarcasm).

Dr. Barry Dworkin

Medical Mythbusting Commentary for April 8, 2021

NACI stands by its four month dosing interval but does not provide further evidence that this will work well for all ages groups and for those with complicating medical conditions. Hope the gamble works (truly, no sarcasm). Play Now | Play in Popup | Download

Source:
Vaccine committee says extending dose interval would allow more essential workers to receive 1st shot

Related posts:

  1. Israeli real-world Pfizer vaccine study reports infection rates dropped by 33% in treatment group of 200K people >60 y.o vs 200K controls after 21 days, less than predicted by proponents of delaying 2nd dose. Stay on schedule until proven otherwise.
  2. Pfizer COVID-19 vaccine news is a press release not a study. No raw data to review, limited transparency, basic questions unanswered, 94 cases, and an overreaction focusing on the claim of 90% efficacy. Validated evidence required to justify the hype.
  3. Israeli study offers more evidence of Pfizer vaccine efficacy with 94% drop in symptomatic cases and 92% decrease in severe illness in people aged 55 and older.—- Restriction-easing plan in Ontario risks Yo-Yo effect once again.
  4. CDC releases study showing that mRNA vaccines perform almost the same in the real world as they did in the lab. Further indications are they prevent disease and its transmission.
Bitnami